Summary
IN this study, rimiterol has been shown to have a rapid, potent and fairly well maintained bronchodilator effect when given as an aerosol.
When given in doses of three (1.5 mg.) and nine (4.5 mg.) times a previously reported ‘reference’ dose (0.5 mg.), there were no statistically significant increases in heart rate and no untoward changes in the electrocardiogram.
The small reductions in arterial oxygen saturation recorded were appreciably less than those reported for the same patients after exercise.
The circadian variation in P.E.F.R. was measured in four asthmatic patients and the increase occurring in the afternoon may mask the waning effect of a bronchodilator drug. This would appear to increase the difficulty of interpreting the results of bronchodilator trials extending over several hours.
Similar content being viewed by others
References
Bowman, W. C. and Rodger, I. W. 1972. Actions of the sympathomimetic bronchodilator, rimiterol (R 789), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetised cat. Brit. J. Pharmac. 45, 574.
Carney, I., Daly, M. J., Lightowler, J. E. and Pickering, R. W. 1971. The comparative pharmacology of WG 253 (rimiterol hydrobromide), a new bronchodilator. Arch. Int. Pharmacodyn. Ther. 194 (Dec.), 334.
Chapman, T. T. and Dowd, D. 1969. Bronchodilator combinations and arterial oxygen tensions in chronic non-specific lung disease. Pharmacologia Clinica. 1, 107.
Chapman, T. T. and Hughes, D. T. 1966. Increasing hypoxia in chronic lung disease following administration of a bronchodilator. J. Irish med. Ass. 59, 184.
Cooke, N. J., Kerr, J. A., Willey, R. F., Hoare, M. V., Grant, I. W. B., Crompton, G. K. 1974. Response of asthmatics and normals to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation. Brit. med. J. ii, 250.
Field, G. B. 1967. The effects of posture, oxygen, isoproternol and atropine on ventilation-perfusion relationships in the lung in asthma. Clin. Sci. 32, 279.
Griffin, J. P. and Turner, P. 1971. Preliminary studies of a new bronchodilator (WG 253) in man. J. Clin. Pharmac. 11, 280.
Harris, L. H. 1970. Effects of isoprenaline plus phenylephrine by pressurised aerosol on blood gases, ventilation and perfusion in chronic obstructive lung disease. Brit med. J. iv, 579.
Harris, L. H. 1972. Comparison of the effect on blood gases, ventilation and perfusion of isoproterenol-phenylephrine and salbutamol aerosols on chronic bronchitis with asthma. J. Allergy. 49, 63.
Hume, K. M. 1970. Blood gas tensions and aerosols. Brit. med. J. i, 173.
Ingram, R. H., Krumpe, P. E., Duffell, G. M., Maniscarlo, B. 1970. Ventilation-perfusion changes after aerosolized isoproterenol in asthma. Amer. Rev. Resp. Dis. 101, 364.
Knudson, R. J. and Constantine, H. P. 1967. An effect of isoproterenol on ventilation-perfusion in asthmatic versus normal subjects. J. Appl. Physiol. 22, 402.
Phillips, E. M., Woolnough, M., Marinova, V. M. and Turner, P. 1972. A comparison of isoprenaline, salbutamol and rimiterol inhalation on skin temperature, heart rate and respiration in man. J. Clin. Pharmacol. 4, 158.
Prime, F. J. and Kamburoff, P. L. 1972. Single shots v. divided doses of a bronchodilator in the relief of reversible airways obstruction. Lancet i, 753.
Reinberg, A., Gervais, P., Frambourg, J. C., Hallberg, F., Abulker, C. H., Vignaud, D. and Dupont, J. 1970. Rhythmes curcadiene de fonctions respiratoires et de la temperature d’asthmatiques sejournant en milieu hypoallergenique. Presse Med. 78, 1817.
Sankey, G. H. and Whiting, K. D. E. 1972. Cyclic adrenaline derivatives, Aryl-2-Piperidyl-Carbinols. J. Heterocyclic Chemistry, 9, 1049.
Svedmyr, N., Malmberg, R. and Thringer, G. 1972. The effect of a new adrenergic beta2-receptor stimulating agent (rimiterol, R 798) in patients with chronic obstructive lung disease. Scand. J. Resp. Dis. 53, 302.
Tai, E. and Read, J. 1967. Response of blood gas tensions to aminophylline and isoprenaline in patients with asthma. Thorax, 22, 543.
Turner, P. and Griffin, J. P. 1971. Antagonism of acetylcholine-induced bronchospasm by WG 253, a new sympathomimetic amine. J. Pharm. Pharmac. 23, 632.
Ulmer, W. T., de Millas, H. and Reichel. 1972. Circadian bronchomotor rhythm under bronchodilator treatment. European Society for Clinical Respiratory Physiology, p. 147–148.
Warrell, D. A., Robertson, D. G., Newton Howes, J., Connolly, M. E., Paterson, J. W., Beilin, L. J. and Dollery, C. T. 1970. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Brit. med. J. i, 65.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linehan, W.D. A new bronchodilator, rimiterol hydrobromide (R 798): An open study of the bronchodilator, cardiovascular and arterial oxygen changes in asthmatic patients. IJMS 144, 144–156 (1975). https://doi.org/10.1007/BF02939005
Issue Date:
DOI: https://doi.org/10.1007/BF02939005